Glaucoma surgery devices market to reach $4.21 billion by 2030

The glaucoma surgery devices market is projected to grow from $2.13 billion in 2025 to $4.21 billion by 2030, driven by rising glaucoma cases, wider use of minimally invasive surgery and better eye care access. North America led the market in 2025 and is expected to stay on top through 2026.

Why it matters: - The glaucoma surgery devices market is expanding as more patients need procedures that can lower eye pressure and help prevent irreversible vision loss. - Demand is rising alongside an aging population, broader access to eye care and greater use of less invasive surgical approaches. - The market’s growth signals more room for medical device makers, hospitals and outpatient eye surgery providers.

What happened: - The glaucoma surgery devices market was valued at $2.13 billion in 2025 and is projected to reach $2.44 billion in 2026. - The market is forecast to climb to $4.21 billion by 2030, implying a 14.6% compound annual growth rate. - North America held the largest share of the market in 2025 and is expected to remain the leading region through 2026. - The Business Research Company published a report on the market and offered a free sample report and the full market report.

The details: - Rising glaucoma incidence, higher ophthalmic surgery volumes, more early-intervention awareness and better eye care infrastructure have supported recent growth. - The report points to aging populations, wider adoption of minimally invasive glaucoma surgery techniques, more ophthalmic research funding, stronger demand for outpatient eye surgery and broader access to advanced treatments as future growth drivers. - Glaucoma surgery devices are designed to improve aqueous humor outflow and lower intraocular pressure. - The devices are used to help prevent optic nerve damage and slow disease progression. - The report says glaucoma is a group of eye disorders that can lead to blindness if untreated. - The Centers for Disease Control and Prevention reported in May 2024 that more than 3 million Americans were affected by glaucoma in 2025, with that number projected to rise to 6.3 million by 2050. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa in addition to North America. - The 2026 report format includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, key technology analysis, future trend analysis, updated graphics and tables.

Between the lines: - The combination of more glaucoma cases and a shift toward outpatient and minimally invasive procedures suggests continued demand for devices that reduce surgical burden. - North America’s lead likely reflects stronger infrastructure, higher awareness and faster access to advanced surgical technology. - The report’s emphasis on dashboards, scoring tools and hotspot maps suggests buyers are looking for more granular market intelligence, not just top-line growth rates.

What's next: - The market is expected to keep growing at a 14.6% CAGR through 2030. - Adoption of MIGS and other advanced glaucoma treatments is likely to remain a central growth factor. - Expanding patient pools and continued investment in ophthalmic care should keep pressure on suppliers to innovate and scale. - The company also provided contact details for expert inquiries and social channels, including LinkedIn, LinkedIn, Facebook and X/Twitter.

The bottom line: - Glaucoma surgery devices are moving from a niche medical segment into a faster-growing global market powered by aging demographics, more diagnosis and wider use of less invasive surgery.